Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo.
Pamela LelandHeba DegheidyAshley LeaSteven R BauerRaj K PuriBharat H JoshiPublished in: Clinical and translational medicine (2024)
Taken together, we conclude that the novel scFv-IL-13Rα2 CAR-T cell therapy may offer an effective therapeutic option after designing a careful pre-clinical and clinical study.